Scaling up a Nanoimmunotherapy for Atherosclerosis Through Preclinical Testing (1 of 8) (IMAGE)

American Association for the Advancement of Science (AAAS)

Scaling up a Nanoimmunotherapy for Atherosclerosis Through Preclinical Testing (1 of 8)

Caption

The new imaging technique was used to guide nanoimmunotherapy (S-HDL) and study blood vessel inflammation in rabbits (top) and pigs (bottom). This material relates to a paper that appeared in the Aug. 21, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by T. Binderup at Icahn School of Medicine at Mount Sinai in New York, NY; and colleagues was titled, "Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species."

Credit

T. Binderup <i>et al., Science Translational Medicine</i> (2019)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.